Cargando…
Titratable Pharmacological Regulation of CAR T Cells Using Zinc Finger-Based Transcription Factors
SIMPLE SUMMARY: Chimeric antigen receptor (CAR) T cell therapy can be associated with substantial side effects primarily due to intense immune activation following treatment, or target antigen recognition on off-tumor tissue. Consequently, temporal and tunable control of CAR T cell activity is of ma...
Autores principales: | Kotter, Bettina, Engert, Fabian, Krueger, Winfried, Roy, Andre, Rawashdeh, Wael Al, Cordes, Nicole, Drees, Britta, Webster, Brian, Werchau, Niels, Lock, Dominik, Dapa, Sandra, Schneider, Dina, Ludwig, Stephan, Rossig, Claudia, Assenmacher, Mario, Mittelstaet, Joerg, Kaiser, Andrew D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8507528/ https://www.ncbi.nlm.nih.gov/pubmed/34638227 http://dx.doi.org/10.3390/cancers13194741 |
Ejemplares similares
-
Combined targeting of soluble latent TGF-ß and a solid tumor-associated antigen with adapter CAR T cells
por: Werchau, Niels, et al.
Publicado: (2022) -
Adapter-Mediated Transduction with Lentiviral Vectors: A Novel Tool for Cell-Type-Specific Gene Transfer
por: Cordes, Nicole, et al.
Publicado: (2022) -
Anti-CD19 CARs displayed at the surface of lentiviral vector particles promote transduction of target-expressing cells
por: Cordes, Nicole, et al.
Publicado: (2021) -
Novel adapter CAR-T cell technology for precisely controllable multiplex cancer targeting
por: Seitz, Christian M., et al.
Publicado: (2021) -
Automated, scaled, transposon-based production of CAR T cells
por: Lock, Dominik, et al.
Publicado: (2022)